IPO Guru
Bajaj
Closed Mainboard

Syncom Healthcare IPO

Syncom Healthcare IPO — date, price band, lot size & details 2010

Syncom Healthcare listed on 15 Feb 2010 at ₹89.9, 19.9% above the ₹75 issue price.

Syncom Healthcare is a central India pharmaceutical company making ethical, OTC, generic and herbal formulations under its own brands and for other companies. Its total income was Rs 19.33 crore in FY2009.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

Timetable

Key dates from opening to listing. Today is 12 November.

Key dates Listed
  1. Open 27 Jan 2010
  2. Close 29 Jan 2010
  3. Allotment 05 Feb 2010
  4. Refund/credit TBA
  5. Listing 15 Feb 2010

Issue summary

The terms of the offer, as filed.

IPO Dates 27 to 29 Jan, 2010
Price Band ₹65 – ₹75
Face Value ₹10
Lot Size 90 Shares
Issue Size ₹56.25 Cr
Sale Type Fresh capital only
Listing On BSE, NSE
Registrar MUFG Intime India Private Limited
Min Investment ₹ 6,750
Reservation
QIB 50%
NII 15%
Retail 35%

Share of the offer set aside for each investor category, as stated in the offer document.

What will it cost me?

Bidding is in multiples of 90 shares at the ₹75 cut-off. Drag to size your application.

shares
1 lot lots
Application Lots Shares Amount
Retail (min) 1 90 ₹6,750
Retail (max) 29 2,610 ₹1,95,750
S-HNI (min) 30 2,700 ₹2,02,500
S-HNI (max) 148 13,320 ₹9,99,000
B-HNI (min) 149 13,410 ₹10,05,750

Strengths & risks

Drawn from the offer document — the case for and against, side by side.

Strengths · 4

  • 01Total borrowing fell from Rs 30.39 crore in FY2007 to Rs 0.90 crore on 31 July 2009.
  • 02It had over 250 products under its own brands.
  • 03Its contract manufacturing range covered over 400 products.
  • 04Rs 20.48 crore of the issue was for a new manufacturing unit at the Indore SEZ.

Risks · 5

  • 01Total income fell from Rs 54.95 crore in FY2007 to Rs 19.33 crore in FY2009.
  • 02Profit after tax fell from Rs 3.67 crore in FY2007 to Rs 0.23 crore in FY2009.
  • 03Net worth was only Rs 2.93 crore on 31 July 2009, against an issue of Rs 56.25 crore.
  • 04The new Indore SEZ unit and the Dehradun upgrade, costing Rs 20.48 crore and Rs 6.62 crore, carry execution risk.
  • 05Promoters held 100% before the issue and 57.14% after it.

Three years of numbers

All figures in ₹ crore, as reported in the Syncom Healthcare offer document.

Total income
15.56
31
19
16
31 Mar 200831 Mar 200931 Jul 2009
Profit after tax
0.06
3
0
0
31 Mar 200831 Mar 200931 Jul 2009
Borrowing vs net worth
0.90 / 2.93
31 Mar 200831 Mar 200931 Jul 2009
Borrowing Net worth
Metric 31 Jul 2009 31 Mar 2009 31 Mar 2008 31 Mar 2007
Total Income 15.56 19.33 30.73 54.95
Profit After Tax 0.06 0.23 2.74 3.67
NET Worth 2.93 5.60 9.45 15.78
Reserves and Surplus 0.67 0.98 3.91 7.87
Total Borrowing 0.90 5.21 20.18 30.39

See how this IPO compares — view listing performance of all mainboard IPOs.

Valuation & key ratios

Ratios are for the latest full financial year reported in the Syncom Healthcare RHP.

RoNW
17.91%

Where the money goes

₹57.49 Cr of the issue is earmarked to named objects.

To set up new manufacturing unit at Indore SEZ ₹20.48 Cr
To undertake the Upgradation/modernization of manufacturing facilities at Dehradun Plant ₹6.62 Cr
To meet working capital requirements ₹15.00 Cr
For opening Export Office at Mumbai ₹4.00 Cr
For Brand & Product Registration and Approval ₹3.00 Cr
General Corporate Purposes ₹2.92 Cr
Issue Expenses ₹5.47 Cr

About the company

Syncom Healthcare Limited was originally incorporated on 29 July 2002 with the Registrar of Companies, Maharashtra, Mumbai. Its promoters are Ajay Bankda and Jyoti Bankda.

It makes, markets and trades pharmaceutical formulations in tablets, capsules, liquids, ointments, eye and ear drops, dry syrups and herbal products. It had over 250 products under its own brands.

It also works as a contract manufacturer for domestic and multinational companies, with a range of over 400 products, and its manufacturing premises span over 1,25,000 sq ft.

The IPO was Rs 56.25 crore and was entirely fresh issue at Rs 75 per share. The money was planned for a new unit at the Indore SEZ, upgrading its Dehradun plant, working capital and an export office in Mumbai.

Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.

Promoters
Ajay Bankda and Jyoti Bankda
Promoter holding
100% → 57.14%
Pre-issue → post-issue

The bankers & the filings

Who is running the book, and the documents this page is built from.

Book-running lead manager
Chartered Capital & Investment Ltd View track record →
Red Herring Prospectus
SEBI filing
Final offer document — price band, financials and risk factors. This page is built from it.
Open the RHP

Syncom Healthcare IPO Documents

Read the filings this page is built from.

Lead Manager Track Record

How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.

Listed in Profit 92.3% 12 of 13 listed
Avg Listing Gain +10.5% across 13 issues
Listed Below Issue 1 of 13 listed

Best listing: Celestial Labs (+25.0%). Weakest: AMD Metplast (-2.7%).

Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.

Company contact

Company
Syncom Healthcare
Email

Frequently asked

What is the GMP of Syncom Healthcare?

The current Grey Market Premium is ₹0.

What is the Syncom Healthcare IPO price band?

₹65 to ₹75, on a face value of ₹10.

When is the allotment?

The basis of allotment is 5 February 2010, with listing on 15 February 2010.

How do I check allotment status?

On the IPO Guru allotment page or on the registrar's site — MUFG Intime India Private Limited.

Syncom Healthcare IPO

Every number here traces back to a filing.

IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.

Join the WhatsApp channel All mainboard IPOs

Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.

GMP
₹0
Subscribed
5.17×
Min bid
₹6,750
Size my application
Advertisement